Eris Lifesciences Limited — Others, 24-12-2024: Trading Window

Eris Lifesciences has announced a board meeting on January 1, 2025, to discuss the financial results for the quarter and nine months ending December 31, 2024. During this period, the trading window for all Designated Persons and their immediate relatives will be closed until 48 hours post-announcement of the results. This measure is aimed at ensuring compliance with insider trading regulations and maintaining transparency. Investors may view this as a proactive step to safeguard against potential stock price manipulation, fostering a positive outlook for corporate governance while staying aware of trading restrictions.